Comparison of direct oral anticoagulants and warfarin regarding midterm adverse events in patients with atrial fibrillation undergoing catheter ablation.

Yuichiro SagawaYasutoshi NagataTetsuo YamaguchiTakamasa IwaiJunji YamaguchiSadahiro HijikataKeita WatanabeRyo MasudaRyoichi MiyazakiNaoyuki MiwaMasahiro SekigawaNobuhiro HaraToshihiro NozatoKenzo Hirao

Published in: Journal of arrhythmia (2018)

Direct oral anticoagulant use in AF patients undergoing CA may be associated with a similar risk of TE as warfarin but is associated with a lower risk of bleeding.

Keyphrases

atrial fibrillation
direct oral anticoagulants
catheter ablation
patients undergoing
left atrial
left atrial appendage
oral anticoagulants
heart failure
venous thromboembolism
protein kinase